PCV13: Clinical Trials

19 trials of PCV13, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 unknown, 1 withdrawn. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Completed 15, Unknown 3, Withdrawn 1

Follow PCV13: new trials by email Literature Review of PCV13 trials Research Report on PCV13

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
PPV23, PCV13, Saline for injection - Streptococcus Pneumonia
Phase 4UnknownLiverpool School of Tropical Medicine5162021-07-282023-01-05
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine - Plasma Cell Neoplasm
Phase 4CompletedEmory University1652019-10-182025-02-28
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years
PCV13 - Pneumonia
Phase 4CompletedBeijing Minhai Biotechnology Co., Ltd6212019-09-262024-01-18
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
PCV10, PCV13 - Pneumococcal Infection, Streptococcus Pneumoniae Infection
Phase 4CompletedLondon School of Hygiene and Tropical Medicine21002019-03-212024-11-12
Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia
PCV13, PPSV23 - CLL, Vaccine Response
Phase 4CompletedRegion Örebro County772019-01-012023-03-30
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
PCV13, DTaP, HBV - Apnea, Apnea Neonatal
Phase 4CompletedDuke University2232018-07-172024-02-14
Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels
PCV13, PPV23 - Pneumococcal Infections
Phase 4CompletedJena University Hospital1232017-10-182023-12-01
Pneumococcal Vaccines in Patients With Asthma
PCV13, PPSV23 - Asthma
Phase 4CompletedMayo Clinic172017-10-012021-11-05
Fever After Simultaneous Versus Sequential Vaccination in Young Children
PCV13, DTaP, IIV - Fever After Vaccination, Fever
Phase 4CompletedDuke University2212017-08-252024-11-18
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
13-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine - Rheumatoid Arthritis, Systemic Lupus
Phase 4CompletedRegion Skane3002016-06-142023-03-29
Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients
PCV13, PPV23 - HIV Infection
Phase 4UnknownAghia Sophia Children's Hospital of Athens402015-12-012017-02-02
Vaccinating Children After Chemotherapy
Prevnar®13, Pneumovax® 23, Pediacel® - Acute Lymphoblastic Leukemia
Phase 4CompletedCanadian Immunization Research Network1562015-11-162022-06-24
Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status
Prevnar 13 - Pneumonia, Streptococcus Pneumoniae
Phase 4CompletedSt. Antonius Hospital602014-04-012014-12-23
Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life
Prevenar13, Synflorix - Otitis Media, Febrile Illness
Phase 4CompletedMenzies School of Health Research2612013-03-122020-03-25
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
Prevenar-13, Pneumo-23 - Chronic Obstructive Pulmonary Disease, Asthma
Phase 4CompletedMikhael Petrovich Kostinov2192012-09-062020-02-25
Pneumococcal Vaccines Early and in Combination
Synflorix, Prevenar13, COMBO - Otitis Media
Phase 4CompletedMenzies School of Health Research4252011-08-012018-10-18
B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals
PCV13 - Asplenia, β-thalassemia Major
Phase 4UnknownAghia Sophia Children's Hospital of Athens372010-10-012013-05-06
13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study
PCV13 - Pneumococcal Disease
Phase 4CompletedUniversity of Oxford1002010-04-012011-03-22
Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants
Synflorix, Prevenar13 - Vaccination, Immunization
Phase 4WithdrawnPublic Health England2019-08-28

Conditions studied

Pneumococcal Infections (5)  ·  Pneumonia (4)  ·  Asthma (2)  ·  Otitis Media (2)  ·  Apnea (1)  ·  Arthritis, Rheumatoid (1)  ·  Cough (1)  ·  Fever (1)  ·  HIV Infections (1)  ·  Influenza, Human (1)  ·  Neoplasms, Plasma Cell (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Premature Birth (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Tract Infections (1)

Sponsors

Aghia Sophia Children's Hospital of Athens (2)  ·  Duke University (2)  ·  Menzies School of Health Research (2)  ·  Beijing Minhai Biotechnology Co., Ltd (1)  ·  Canadian Immunization Research Network (1)  ·  Emory University (1)  ·  Jena University Hospital (1)  ·  Liverpool School of Tropical Medicine (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Mayo Clinic (1)  ·  Mikhael Petrovich Kostinov (1)  ·  Public Health England (1)  ·  Region Skane (1)  ·  Region Örebro County (1)  ·  St. Antonius Hospital (1)

Countries

United States (4)  ·  United Kingdom (3)  ·  Australia (2)  ·  Canada (1)  ·  China (1)  ·  Germany (1)  ·  Greece (1)  ·  Kenya (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Sweden (1)

Top investigators

Amanda J Leach, PhD (2)  ·  Karen Broder, MD (2)  ·  Aleksander V Zhestkov, Professor (1)  ·  Andrea Trembath, MD (1)  ·  Andrei D Protasov, Professor (1)  ·  Andrew Pollard, FRCPCH, PhD (1)  ·  Avni Y Joshi (1)  ·  Bart JM Vlaminckx, Phd (1)  ·  Bertil Uggla, Md, PhD (1)  ·  Craig Hofmeister, MD, MPH (1)  ·  Elizabeth Coates, PhD (1)  ·  Emmanuel B Walter, MD, MPH (1)  ·  Ger T Rijkers, Prof (1)  ·  Gertjan H Wagenvoort, MD (1)  ·  J. Anthony G Scott, DTMH FMedSci (1)

Results publications

PMID 35772449, PMID 38829821, PMID 24618837, PMID 24879786, PMID 25596202, PMID 27239929, PMID 28392142, PMID 28802755, PMID 29488477, PMID 29722823, PMID 30683996, PMID 32029684, PMID 32067048, PMID 32087733, PMID 32448790, PMID 33685411, PMID 35798520, PMID 39217777, PMID 39330966, PMID 39761016, PMID 40045895, PMID 41698388, PMID 42743942

NIH funding

P30CA138292 (1)